Design a novel 5HT2c agonist for the treatment of serotonin related disorders

被引:0
|
作者
Liu, Kevin K-C. [1 ]
机构
[1] Pfizer Inc, Discovery Chem, La Jolla, CA 92121 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
80-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Alleles at the serotonin receptor 5HT2C are associated with eating disorders and related psychopathological traits
    Ribasés, M
    Mercader, JM
    Gratacòs, M
    Morell, M
    Badía, A
    Jiménez, L
    Solano, R
    Fernandez-Aranda, F
    Estivill, X
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 96 - 96
  • [2] The synthesis of a 5HT2c receptor agonist
    Hobson, Lindsay A.
    Nugent, William A.
    Anderson, Stephen R.
    Deshmukh, Subodh S.
    Haley, James J., III
    Liu, Pingli
    Magnus, Nicholas A.
    Sheeran, Patrick
    Sherbine, James P.
    Stone, Benjan R. P.
    Zhu, Jiang
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2007, 11 (06) : 985 - 995
  • [3] Alcohol dependence and serotonin receptor 5HT2c
    Yoshimoto, Kanji
    Ueda, Shuichi
    Kobayasi, Masaki
    Ishikawa, Noboru
    Sakabe, Masaaki
    Hara, Junpei
    Funaki, Hironao
    Watanabe, Yoshihisa
    Tanaka, Masaki
    Ikegaya, Hiroshi
    NEUROSCIENCE RESEARCH, 2009, 65 : S256 - S256
  • [4] Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity
    Liu, Kevin K. -C.
    Cornelius, Peter
    Patterson, Terrell A.
    Zeng, Yuan
    Santucci, Stephanie
    Tomlinson, Elizabeth
    Gibbons, Colleen
    Maurer, Tristan S.
    Marala, Ravi
    Brown, Janice
    Kong, Jimmy X.
    Lee, Eunsun
    Werner, Wendy
    Wenzel, Zane
    Vage, Chandra
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 266 - 271
  • [5] Design and synthesis of tryptamine-based 5HT2C agonists for the treatment of certain CNS disorders
    Leit, Silvana
    Elder, Amy
    Wilson, Douglas
    Hunt, Rachel
    Li, Bing
    Wiig, Kjesten
    Song, Jianping
    Sard, Howard P.
    Roth, Bryan
    Morency, Cynthia
    Kumaran, Govindaraj
    Xu, Liang
    Li, Jie
    Zhang, Yiliang
    Reddy, Ravi
    Gerber, David
    Harriman, Geraldine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [6] Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
    Christina T. Egan
    Katharine Herrick-Davis
    Keith Miller
    Richard A. Glennon
    M. Teitler
    Psychopharmacology, 1998, 136 : 409 - 414
  • [7] Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors
    Egan, CT
    Herrick-Davis, K
    Miller, K
    Glennon, RA
    Teitler, M
    PSYCHOPHARMACOLOGY, 1998, 136 (04) : 409 - 414
  • [8] Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor
    Mancia, Filippo
    Assur, Zahra
    Herman, Ariel G.
    Siegel, Risa
    Hendrickson, Wayne A.
    EMBO REPORTS, 2008, 9 (04) : 363 - 369
  • [9] Serotonin 5-HT2C receptor homodimerization is not regulated by agonist or inverse agonist treatment
    Herrick-Davis, Katharine
    Grinde, Ellinor
    Weaver, Barbara A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 568 (1-3) : 45 - 53
  • [10] Combined effects of a serotonin 5HT2C receptor agonist and a serotonin 5HT2A receptor antagonist on methamphetamine-induced sleep disruption evaluated with actigraphy in rhesus monkeys
    Berro, Lais Fernanda
    Diaz, Maylen Peres
    Andersen, Monica Levy
    Howell, Leonard
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E19 - E19